Accessibility settings

This paper is in the following e-collection/theme issue:

Electronic/Mobile Data Capture, Internet-based Survey & Research Methodology (1713) E-Health Policy and Health Systems Innovation (507) Knowledge Translation and Implementation Science (756) Innovations in Clinical Trials and Research Data Management (208)

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/80625, first published .
Hand holding blood glucose meter showing 9.7 reading

Addressing the Key Challenges of Decentralized Clinical Trials in Europe: Multistakeholder Perspective Delphi Study

Addressing the Key Challenges of Decentralized Clinical Trials in Europe: Multistakeholder Perspective Delphi Study

Authors of this article:

Carlos Murciano-Gamborino1, 2 Author Orcid Image ;   Lina Pérez-Breva1 Author Orcid Image ;   Amos J de Jong3 Author Orcid Image ;   Martin Boeckhout4 Author Orcid Image ;   Ghislaine Jose Madeleine Wilhelmien van Thiel3 Author Orcid Image ;   Kate Huntley5 Author Orcid Image ;   Hamidou Traore6 Author Orcid Image ;   Helga Gardarsdottir7, 8, 9 Author Orcid Image ;   Jaime Fons-Martinez1, 2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Carlos Murciano-Gamborino   1, 2 , BA ;   Lina Pérez-Breva   1 , PhD ;   Amos J de Jong   3 , PhD ;   Martin Boeckhout   4 , PhD ;   Ghislaine Jose Madeleine Wilhelmien van Thiel   3 , PhD ;   Kate Huntley   5 , BSc (Hons) ;   Hamidou Traore   6 , PhD ;   Helga Gardarsdottir   7, 8, 9 , PhD ;   Jaime Fons-Martinez   1, 2 , PhD

1 Vaccines Research Area, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO-Public Health), Valencia, Spain

2 Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), ISCIII, Madrid, Spain

3 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands

4 Rotterdam University of Applied Sciences, Rotterdam, The Netherlands

5 Pfizer R&D UK Limited, Walton-on-the-Hill, United Kingdom

6 UCB Biopharma, Brussels, Belgium

7 Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

8 Department of Clinical Pharmacy, Division Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands

9 Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland

Corresponding Author:

  • Jaime Fons-Martinez, PhD
  • Vaccines Research Area, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO-Public Health)
  • Avenida Cataluña, 21
  • Valencia 46020
  • Spain
  • Phone: 34 961925948
  • Email: jaime.fons@fisabio.es